Platelet-rich plasma (PRP) and tendon healing: comparison between fresh and frozen-thawed PRP

[en] Platelet-rich plasma (PRP) is increasingly used in the treatment of musculoskeletal diseases. Its preservation by freezing it for the realization of multiple injections in clinical use has never been discussed. Calcaneal tendons of rats were surgically sectioned. Platelet concentration of the PRP was 2.5 x 106/μl with autologous plasma of rats. Frozen-thawed PRP was prepared by performing two cycles of freezing and thawing on PRP aliquots. Both platelet preparations were injected in the lesion. Biomechanical and histological evaluations were carried out after 7, 20 or 40 days post surgery. After 7 and 40 days, no significant difference was observed between the PRP and the frozen-thawed PRP group. There is however a difference 20 days after surgery: the ultimate tensile strength (UTS) was greater in the fresh PRP group. No obvious difference with histological aspect was observed between the two groups. In conclusion, fresh PRP and frozen-thawed PRP injections can lead to similar results in the healing process of section calcaneal tendons of rats. Improvements with fresh PRP are slight. PRP could thus be frozen to be preserved if multiple injections are needed (e.g. osteoarthritis).

Disciplines :

Orthopedics, rehabilitation & sports medicine

Author, co-author :

KAUX, Jean-François ; Centre Hospitalier Universitaire de Liège - CHU > Autres Services Médicaux > Service de médecine de l'appareil locomoteur

Libertiaux, Vincent

Dupont, Laura ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Laboratoire des tissus conjonctifs

Colige, Alain ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Laboratoire des tissus conjonctifs

Denoël, Vincent ; Université de Liège - ULiège > Département ArGEnCo > Analyse sous actions aléatoires en génie civil

LECUT, Christelle ; Centre Hospitalier Universitaire de Liège - CHU > Unilab > Unité de laboratoire - thrombose - hémostase

Hego, Alexandre ; Université de Liège - ULiège > Platform Imaging & Flow cytometry

Gustin, Maxime ; Université de Liège - ULiège > Cardiovascular Sciences-Cardiology

Duwez, Luc ; Université de Liège - ULiège > GIGA Research (AFT)

Oury, Cécile ; Université de Liège - ULiège > Cardiovascular Sciences-Cardiology

More authors (3 more)

Language :

English

Title :

Platelet-rich plasma (PRP) and tendon healing: comparison between fresh and frozen-thawed PRP

Publication date :

February 2020

Journal title :

Platelets

ISSN :

0953-7104

eISSN :

1369-1635

Publisher :

Taylor & Francis, United Kingdom

Volume :

Issue :

Pages :

221-225

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 27 March 2019

Statistics

Number of views

299 (49 by ULiège)

Number of downloads

20 (19 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Kaux JF, Drion P, Croisier JL, Crielaard JM. Tendinopathies and platelet-rich plasma (PRP): from pre-clinical experiments to therapeutic use. J Stem Cells Regen Med 2015 May 30;11(1):7–17.
Maffulli N, Del Buono A., Platelet plasma rich products in musculoskeletal medicine: any evidence? Surgeon 2012 Jun;10(3):148–150. doi:10.1016/j.surge.2011.03.004
Zhang JY, Fabricant PD, Ishmael CR, Wang JC, Petrigliano FA, Jones KJ. Utilization of platelet-rich plasma for musculoskeletal injuries: an analysis of current treatment trends in the United States. Orthop J Sports Med 2016 Dec 21;4(12):2325967116676241.
Campbell KA, Saltzman BM, Mascarenhas R, Khair MM, Verma NN, Bach BR Jr, Cole BJ. Does intra-articular platelet-rich plasma injection provide clinically superior outcomes compared with other therapies in the treatment of knee osteoarthritis? A systematic review of overlapping meta-analyses. Arthroscopy 2015 Nov;31(11):2213–2221. doi:10.1016/j.arthro.2015.03.041
Milants C, Bruyère O, Kaux JF., Responders to platelet-rich plasma in osteoarthritis: a technical analysis. Biomed Res Int 2017;2017:7538604. doi:10.1155/2017/7538604
Bruyère O, Cooper C, Cutolo M, Reginster JY. International endorsement of the ESCEO algorithm for management of knee osteoarthritis in clinical practice. Semin Arthritis Rheum 2017 Oct;47(2):e10. doi:10.1016/j.semarthrit.2017.07.002
Reginster JY, Reiter-Niesert S, Bruyère O, Berenbaum F, Brandi ML, Branco J, Devogelaer JP, Herrero-Beaumont G, Kanis J, Maggi S, et al. Recommendations for an update of the 2010 European regulatory guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis and reflections about related clinically relevant outcomes: expert consensus statement. Osteoarthritis Cartilage 2015 Dec;23(12):2086–2093. doi:10.1016/j.joca.2015.07.001
Smets F, Croisier JL, Forthomme B, Crielaard JM, Kaux JF. Applications cliniques du plasma riche en plaquettes (PRP) dans les lésions tendineuses: revue de la literature. Science & Sport 2012;27(2):141–153. doi:10.1016/j.scispo.2011.12.007
Kaux JF, Bouvard M, Lecut C, Oury C, Gothot A, Sanchez M, Crielaard JM. Reflections about the optimisation of the treatment of tendinopathies with PRP. Muscles Ligaments Tendons J 2015 Mar 27;5(1):1–4.
Kaux JF, Emonds-Alt T. The use of platelet-rich plasma to treat chronic tendinopathies: a technical analysis. Platelets 2017 Jul 31;1–15. doi:10.1080/09537104.2017.1336211 [Epub ahead of print].
Anitua E,de la Fuente M, Riestra A, Merayo-Lloves J, Muruzábal F, Orive G. Preservation of biological activity of plasma and platelet-derived eye drops after their different time and temperature conditions of storage. Cornea 2015 Sep;34(9):1144–1148. doi:10.1097/ICO.0000000000000489
Strandberg G, Sellberg F, Sommar P, Ronaghi M, Lubenow N, Knutson F, Berglund D. Standardizing the freeze-thaw preparation of growth factors from platelet lysate. Transfusion 2017 Apr;57(4):1058–1065. doi:10.1111/trf.13998
Roffi A, Filardo G, Assirelli E, Cavallo C, Cenacchi A, Facchini A, Grigolo B, Kon E, Mariani E, Pratelli L, et al. Does platelet-rich plasma freeze-thawing influence growth factor release and their effects on chondrocytes and synoviocytes? Biomed Res Int 2014;2014:692913. doi:10.1155/2014/692913
Kaux JF, Drion PV, Colige A, Pascon F, Libertiaux V, Hoffmann A, Janssen L, Heyers A, Nusgens BV, Le Goff C, et al. Effects of platelet-rich plasma (PRP) on the healing of Achilles tendons of rats. Wound Repair Regen 2012 Sep-Oct;20(5):748–756. doi:10.1111/j.1524-475X.2012.00826.x
Kaux JF, Janssen L, Drion P, Nusgens B, Libertiaux V, Pascon F, Heyeres A, Hoffmann A, Lambert C, Le Goff C, et al. Vascular endothelial growth factor-111 (VEGF-111) and tendon healing: preliminary results in a rat model of tendon injury. Muscles Ligaments Tendons J 2014 May 8;4(1):24–28.
Greimers L, Drion PV, Colige A, Libertiaux V, Denoël V, Lecut C, Gothot A, Kaux JF. Effects of allogeneic Platelet-Rich Plasma (PRP) on the healing process of sectioned achilles tendons of rats: a methodological description. J Vis Exp. 2018 Mar 19;(133).
Kaux JF, Drion P, Libertiaux V, Colige A, Hoffmann A, Nusgens B, Besançon B, Forthomme B, Le Goff C, Franzen R, et al. Eccentric training improves tendon biomechanical properties: a rat model. J Orthop Res 2013 Jan;31(1):119–124. doi:10.1002/jor.22202
Kaux JF, Libertiaux V, Leprince P, Fillet M, Denoel V, Wyss C, Lecut C, Gothot A, Le Goff C, Croisier JL, et al. Eccentric training for tendon healing after acute lesion: a rat model. Am J Sports Med 2017 May;45(6):1440–1446. doi:10.1177/0363546517689872
Virchenko O, Aspenberg P. How can one platelet injection after tendon injury lead to a stronger tendon after 4 weeks? Interplay between early regeneration and mechanical stimulation. Acta Orthop 2006 Oct;77(5):806–812. doi:10.1080/17453670610013033
Wieloch P, Buchmann G, Roth W, Rickert M. A cryo-jaw designed for in vitro tensile testing of the healing Achilles tendons in rats. J Biomech 2004 Nov;37(11):1719–1722. doi:10.1016/j.jbiomech.2004.01.027
Alio JL, Rodriguez AE, Ferreira-Oliveira R, Wróbel-Dudzińska D, Abdelghany AA. Treatment of dry eye disease with autologous platelet-rich plasma: a prospective, interventional, non-randomized study. Ophthalmol Ther 2017 Dec;6(2):285–293. doi:10.1007/s40123-017-0100-z
Kaux JF, Croisier JL, Bruyere O, Rodriguez De La Cruz C, Forthomme B, Brabant G, Lapraille S, Lonneux V, Noel D, Le Goff C, et al. One injection of platelet-rich plasma associated to a submaximal eccentric protocol to treat chronic jumper’s knee. J Sports Med Phys Fitness 2015 Sep;55(9):953–961.
Kaux JF, Bruyere O, Croisier JL, Forthomme B, Le Goff C, Crielaard JM. One-year follow-up of platelet-rich plasma infiltration to treat chronic proximal patellar tendinopathies. Acta Orthop Belg 2015 Jun;81(2):251–256.
Garg S, Manchanda S. Platelet-rich plasma-an ‘Elixir’ for treatment of alopecia: personal experience on 117 patients with review of literature. Stem Cell Investig 2017 Jul;18(4):64. doi:10.21037/sci.2017.06.07
Kaux JF, Croisier JL, Léonard P, Le Goff C, Crielaard JM. Exuberant inflammatory reaction as a side effect of platelet-rich plasma injection in treating one case of tendinopathy. Clin J Sport Med 2014 Mar;24(2):150–152. doi:10.1097/JSM.0b013e31829aa410
Kaux JF, Degrave N, Crielaard JM. Platelet-rich plasma: traitement des tendinopathies chroniques? Revue de la literature. Journal De Traumatologie Du Sport 2007;24(2):99–102. doi:10.1016/j.jts.2007.03.002
Venter NG, Marques RG, Santos JS, Monte-Alto-Costa A. Use of platelet-rich plasma in deep second- and third-degree burns. Burns 2016 Jun;42(4):807–814. doi:10.1016/j.burns.2016.01.002
Kaux JF, Croisier JL, Forthomme B, Le Goff C, Buhler F, Savanier B, Delcour S, Gothot A, Crielaard JM. Using platelet-rich plasma to treat jumper’s knees: exploring the effect of a second closely-timed infiltration. J Sci Med Sport 2016 Mar;19(3):200–204. doi:10.1016/j.jsams.2015.03.006
Baik SY, Lim YA, Kang SJ, Ahn SH, Lee WG, Kim CH. Effects of platelet lysate preparations on the proliferation of HaCaT cells. Ann Lab Med 2014 Jan;34(1):43–50. doi:10.3343/alm.2014.34.1.43
Cowan DH, Graham J. Stimulation of human tumor colony formation by platelet lysate. J Lab Clin Med 1983 Dec;102(6):973–986.
Marck RE, Gardien KLM, Vlig M, Breederveld RS, Middelkoop E. Growth factor quantification of platelet-rich plasma in burn patients compared to matched healthy volunteers. Int J Mol Sci 2019;20:288. doi:10.3390/ijms20020288
Fekete N, Gadelorge M, Fürst D, Maurer C, Dausend J, Fleury-Cappellesso S, Mailänder V, Lotfi R, Ignatius A, Sensebé L. Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identifi cation of active components. Cytotherapy 2012;14:540–554.
Roffi A, Filardo G, Assirelli E, Cavallo C, Cenacchi A, Facchini A, Grigolo B, Kon E, Mariani E, Pratelli L, et al. Does platelet-rich plasma freeze-thawing influence growth factor release and their effects on chondrocytes and synoviocytes? Biomed Res Int 2014;Article ID 692913:10. doi:10.1155/2014/692913
Strandberg G, Sellberg F, Sommar P, Ronaghi M, Lubenow N, Knutson F, Berglund D. Standardizing the freeze-thaw preparation of growth factors from platelet lysate. Transfusion 2017;57:1058–1065. doi:10.1111/trf.14228
van den Dolder J, Mooren R, Vloon AP, Stoelinga PJ, Jansen JA. Platelet-rich plasma: quantification of growth factor levels and the effect on growth and differentiation of rat bone marrow cells. Tissue Eng 2006 Nov;12(11):3067–3073. doi:10.1089/ten.2006.12.3067